Navigation Links
Solutia Reports First Quarter 2009 Results
Date:5/6/2009

German subsidiary obtains $74 million term loan

ST. LOUIS, May 6 /PRNewswire-FirstCall/ --

2009 First Quarter Highlights

  • Net sales decreased to $339 million from $517 million in the first quarter of 2008
  • Adjusted EBITDA decreased to $56 million from $95 million in the first quarter of 2008
  • Saflex and Technical Specialties segments report improved Adjusted EBITDA margins
  • The Company's cash generation in the quarter allowed for debt reduction of $50 million
  • Diluted loss per share from continuing operations of $.04; Adjusted loss per share of $.05
  • Maintaining Adjusted EBITDA guidance for the year of $325 million - $350 million
  • Increasing 2009 target for cash from continuing operations less capital spending to $50 million - $100 million

New Term Loan

On May 5, 2009, a Solutia wholly owned German subsidiary entered into a $74 million, two-year senior unsecured term loan facility. The proceeds were used to pay down amounts under Solutia's credit facility.

Note: See reconciliation tables below for adjustments made to GAAP and discussion of items affecting results.

Consolidated Results from Continuing Operations

Solutia Inc. (NYSE: SOA) today reported a consolidated loss from continuing operations of $4 million for the first quarter of 2009, compared to income of $1,234 million for the same period in 2008. These results were impacted by certain events affecting comparability (detailed below) totaling a net gain of $1 million in 2009 and a net gain of $1,210 million in 2008. After adjusting for these items in both periods, co
'/>"/>

SOURCE Solutia Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Solutia to Present at Deutsche Bank Small and Mid Cap Conference
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):New biological route for swine flu to human infections 2New biological route for swine flu to human infections 3'Fighting' IED attacks with SCARE technology 2'Fighting' IED attacks with SCARE technology 3First phase of pan-tropical forest mapping debuting at COP15 2First phase of pan-tropical forest mapping debuting at COP15 3Florida Hospital and Burnham Institute Announce New Executive Director and Facility for Clinical Research Institute 54625 1Florida Hospital and Burnham Institute Announce New Executive Director and Facility for Clinical Research Institute 54625 2Florida Hospital and Burnham Institute Announce New Executive Director and Facility for Clinical Research Institute 54625 3American Humane Association Launches Innovative Therapy Animals Supporting Kids 28TASK 29 28TM 29 Program 54623 1American Humane Association Launches Innovative Therapy Animals Supporting Kids 28TASK 29 28TM 29 Program 54623 2American Humane Association Launches Innovative Therapy Animals Supporting Kids 28TASK 29 28TM 29 Program 54623 3Aurora Health Care Top Performing Health System in National Quality Initiative 54621 1Aurora Health Care Top Performing Health System in National Quality Initiative 54621 2Aurora Health Care Top Performing Health System in National Quality Initiative 54621 3Aurora Health Care Top Performing Health System in National Quality Initiative 54621 4